151
Participants
Start Date
July 31, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
abicipar pegol
Abicipar pegol administered to the study eye by intravitreal injection at the visits noted per protocol.
ranibizumab
Ranibizumab (Lucentis®) administered to the study eye by intravitreal injection every 4 weeks from day 1 through week 24.
sham procedure
Sham procedure to the study eye at the visits noted per protocol.
Gilbert
Abilene
Lead Sponsor
Allergan
INDUSTRY